Using Intellectual Property Rights to Build Your Business
Intellectual property rights are central to building and scaling startups in India. This post discusses the strategic use of IP for business advantage and announces a seminar offering…
1,328 articles
Intellectual property rights are central to building and scaling startups in India. This post discusses the strategic use of IP for business advantage and announces a seminar offering…
This article provides an analytical overview of patent filings by foreign applicants in India over the past decade, including key trends and contributors. It objectively reviews statistical data,…
This post analyses a decade of patent statistics, examining trends in filings, grants, examinations, and revenue in India. It reflects on the evolving landscape of intellectual property rights,…
This article analyses common patent myths and clarifies key aspects of patent law in India. It offers insights on patent eligibility, enforcement, and the importance of professional advice…
Apple Pay aims to transform the banking sector through secure, person-to-person mobile payments using NFC and robust encryption. Its exclusivity to Apple devices and anticipated market impact raise…
This post examines the legal and practical aspects of a new airline seat patent filed by Zodiac Seats France. It discusses the implications for passenger comfort, safety regulations,…
This post discusses the importance of intellectual property and patent protection in hospital management, with reference to Indian law. Key steps for safeguarding inventions and the necessity of…
The INPI has revised its patent procedure fees in France, increasing the overall cost of obtaining and maintaining patents from July 2015. This post analyses the legal and…
The Indian Institute of Science, renowned for research excellence, has filed fewer than fifty patents annually in recent years, with limited commercialization. This analysis examines IISc’s patent trends…
The UK Court of Appeal ruled that Actavis’s alternative salt forms of pemetrexed would indirectly infringe Eli Lilly’s cancer drug patent. The decision provides insights into patent claim…